The Takeda Patient Assistance Program (PAP) provides patients with access to medications
for a variety of conditions. To qualify for free Takeda medication, patients must
meet the following conditions:
- • Resident
of the United States. You must live in the United States
and for some assistance programs must provide proof of residency with either a Social
Security Number, Green Card Number or Visa Number.
- • A total
household income less than 300% of the Your yearly household
income includes all money that comes into your household. If you are married and
live with your spouse, you must include both of your incomes. You must also include
income earned by dependents living with you.
Federal Poverty
Level
- • Patient must have a valid prescription for a Takeda medicine (see the list
below)
- • No prescription coverage through private or government programs
- • Patients who are eligible for or enrolled in Medicare Part D may still apply,
and they may be eligible to receive free Takeda medicines through the end of the
calendar year
Takeda Medicines Available through the Patient Assistance Program
|
Brand Name
|
Generic Name
|
|
ACTOS® 15 mg tablet
|
pioglitazone HCl
|
|
ACTOS® 30 mg tablet
|
pioglitazone HCl
|
|
ACTOS® 45 mg tablet
|
pioglitazone HCl
|
|
ACTOplus met® 15 mg/500 mg tablet
|
pioglitazone HCl + metformin HCl
|
|
ACTOplus met® 15 mg/850 mg tablet
|
pioglitazone HCl + metformin HCl
|
|
ACTOplus met® XR 15 mg/1000 mg
tablet
|
pioglitazone HCl + metformin HCl XR
|
|
ACTOplus met® XR 30 mg/1000 mg
tablet
|
pioglitazone HCl + metformin HCl XR
|
|
AMITIZA® 8 mcg capsule
|
lubiprostone
|
|
AMITIZA® 24 mcg capsule
|
lubiprostone
|
|
DEXILANTTM 30 mg capsule
|
dexlansoprazole
|
|
DEXILANTTM 60 mg capsule
|
dexlansoprazole
|
|
duetact® 30 mg/2 mg tablet
|
pioglitazone HCl and glimepiride
|
|
duetact® 30 mg/4 mg tablet
|
pioglitazone HCl and glimepiride
|
|
Rozerem® 8 mg tablet
|
ramelteon
|
|
ULORIC® 40 mg tablet
|
febuxostat
|
|
ULORIC® 80 mg tablet
|
febuxostat
|
ACTOS, ACTOplus met, ACTOplus met XR and Duetact are trademarks of
Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark
Office and used under license by Takeda Pharmaceuticals America, Inc.
ROZEREM is a trademark of Takeda Pharmaceutical Company Limited registered with
the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals
America, Inc.
DEXILANT is a trademark of Takeda Pharmaceuticals North America, Inc. and used under
license by Takeda Pharmaceuticals America, Inc.
AMITIZA is a trademark of Sucampo Pharmaceuticals, Inc. registered with the U.S.
Patent and Trademark Office and used under license by Takeda Pharmaceuticals America,
Inc.
ULORIC is a trademark of Teijin Pharma Limited registered with the U.S. Patent and
Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.
This program, as well as all Takeda Pharmaceuticals America, Inc. programs, can
be discontinued or changed at any time without notice at the discretion of Takeda
Pharmaceuticals America, Inc.